Raymond James & Associates Medi Wound Ltd. Transaction History

Raymond James & Associates

  • $150 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 04, 2020
SELL
$3.09 - $4.14 $35,485 - $47,543
-11,484 Closed
0 $0
Q1 2020

Apr 21, 2020
SELL
$1.57 - $3.1 $10,983 - $21,687
-6,996 Reduced 37.86%
11,484 $18,000
Q4 2019

Feb 12, 2020
BUY
$2.72 - $3.15 $50,265 - $58,212
18,480 New
18,480 $57,000

About MediWound Ltd.

MDWD Quotes by TradingView
  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $686M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email